分子向的兰化物纳米颗粒用于癌症治疗应用
Guillermina Ferro-Flores1, Alejandra Ancira-Cortez1, Blanca Ocampo-García1
1Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Nanomaterials (Basel, Switzerland)
|February 9, 2024
概括
功能化的兰化物纳米粒子在癌症治疗中表现有前途. 这些生物相容的纳米粒子向瘤蛋白质,并提供先进的成像和治疗应用.
科学领域:
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 兰氧化物纳米颗粒 (10-100nm) 具有高生物相容性和低毒性.
- 生物分子的功能化使得瘤微环境蛋白能够有针对性地传递给瘤.
- 目标蛋白包括叶酸受体,FAP,GRP-R,PSMA和整体蛋白.
研究的目的:
- 审查在癌症中兰化物纳米颗粒的治疗应用.
- 突出功能化纳米颗粒的准能力.
- 为了总结成像和治疗潜力.
主要方法:
- 关于用于癌症治疗的兰他尼德纳米粒子现有文献的综述.
- 对瘤向的纳米粒子功能化策略的分析.
- 评估成像模式和治疗应用.
主要成果:
- 兰化物纳米颗粒可以功能化,以准特定的瘤生物标志物.
- 不同的兰坦化物元素 (Lu,Sm,Eu,Ho,Tb) 显示了光学潜力.
- 应用包括MRI,核,光学,CT成像,光动力疗法和向放射治疗.
结论:
- 兰化物纳米颗粒代表了癌症治疗学的多功能平台.
- 有针对性的功能化增强了特异性和有效性.
- 这些纳米粒子为改善癌症诊断和治疗提供了显著的潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K